Home > Publications database > Incidence and clinical outcomes of ventilator-associated events in Russian tertiary care settings: an analysis of electronic health records. > print

001     300573
005     20250418113046.0
024 7 _ |a 10.1186/s13104-025-07240-0
|2 doi
024 7 _ |a pmid:40234949
|2 pmid
024 7 _ |a pmc:PMC12001673
|2 pmc
037 _ _ |a DKFZ-2025-00806
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Vladimirov, Sergei
|0 0009-0003-4795-1807
|b 0
245 _ _ |a Incidence and clinical outcomes of ventilator-associated events in Russian tertiary care settings: an analysis of electronic health records.
260 _ _ |a London
|c 2025
|b [Verlag nicht ermittelbar]
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1744896379_22801
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:C070#
520 _ _ |a This research aimed to evaluate the epidemiological and clinical characteristics of ventilator-associated events (VAE) using the CDC framework in a tertiary hospital in Moscow, Russia.In this cohort study, we analyzed electronic health records from 407 mechanically ventilated adults who were admitted to the Kommunarka Moscow Multipurpose Clinical Center between September 2022 and December 2023. We identified a total of 35 VAE, resulting in an incidence rate of 8.39 (95% confidence interval, 5.84 to 11.67) events per 1,000 ventilator-days. The presence of VAE was associated with higher ICU mortality by day 30 from the start of mechanical ventilation (adjusted hazard ratio, 1.58; 95% confidence interval, 1.01 to 2.48), particularly in patients with infection-related ventilator-associated complications (adjusted hazard ratio, 2.09; 95% confidence interval, 1.17 to 3.74). The median durations of mechanical ventilation and ICU length of stay were comparable between patients with VAE and those without. Implementing surveillance measures and developing tailored preventive strategies for VAE may be beneficial in similar healthcare settings to improve outcomes for mechanically ventilated patients.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Epidemiology
|2 Other
650 _ 7 |a Infection-related complication
|2 Other
650 _ 7 |a Intensive care
|2 Other
650 _ 7 |a Mechanical ventilation
|2 Other
650 _ 7 |a Ventilator-associated event
|2 Other
650 _ 7 |a Ventilator-associated pneumonia
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Respiration, Artificial: adverse effects
|2 MeSH
650 _ 2 |a Electronic Health Records: statistics & numerical data
|2 MeSH
650 _ 2 |a Incidence
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Tertiary Care Centers: statistics & numerical data
|2 MeSH
650 _ 2 |a Intensive Care Units: statistics & numerical data
|2 MeSH
650 _ 2 |a Length of Stay: statistics & numerical data
|2 MeSH
650 _ 2 |a Pneumonia, Ventilator-Associated: epidemiology
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Hospital Mortality
|2 MeSH
650 _ 2 |a Moscow: epidemiology
|2 MeSH
650 _ 2 |a Russia: epidemiology
|2 MeSH
700 1 _ |a Klimenko, Ilia
|b 1
700 1 _ |a Matiushkov, Nikita
|0 0000-0001-7066-7175
|b 2
700 1 _ |a Protsenko, Denis
|0 0000-0002-5166-3280
|b 3
700 1 _ |a Sergeev, Dmitry
|0 P:(DE-He78)772c4cbbab31f1b71f814e8ae9e0ed51
|b 4
|e Last author
|u dkfz
773 _ _ |a 10.1186/s13104-025-07240-0
|g Vol. 18, no. 1, p. 172
|0 PERI:(DE-600)2413336-X
|n 1
|p 172
|t BMC Research Notes
|v 18
|y 2025
|x 1756-0500
909 C O |o oai:inrepo02.dkfz.de:300573
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)772c4cbbab31f1b71f814e8ae9e0ed51
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-04-10T15:34:54Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-04-10T15:34:54Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2024-04-10T15:34:54Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-02
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2025-01-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-02
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-01-02
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-01-02
920 2 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21